Trial Details
RECRUITINGBasic Information
| Clinical ID | c1904 |
|---|---|
| Identifier | NCT04263831 |
| Trial Title | Low Dose IL-2 for the Treatment of Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Interleukin-2 (aldesleukin). |
Participant Information
| Sponsor | Boston Children's Hospital |
|---|---|
| City | Boston |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2021-03-11 |
|---|---|
| Primary Completion Date | 2026-12-31 |
| Completion Date | 2027-12-31 |